Simplex Trading’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,532
| Closed | -$42K | – | 8961 |
|
|
2025
Q1 | $42K | Sell |
5,532
-1,020
| -16% | -$12.2K | ﹤0.01% | 5940 |
|
|
2024
Q4 | $86K | Buy |
6,552
+432
| +7% | +$4.01K | ﹤0.01% | 5324 |
|
|
2024
Q3 | $61K | Buy |
6,120
+3,500
| +134% | +$52.8K | ﹤0.01% | 5715 |
|
|
2024
Q2 | $58K | Sell |
2,620
-784
| -23% | -$24.2K | ﹤0.01% | 5929 |
|
|
2024
Q1 | $199K | Buy |
3,404
+2,764
| +432% | +$119K | ﹤0.01% | 4872 |
|
|
2023
Q4 | $14K | Sell |
640
-276
| -30% | -$4.16K | ﹤0.01% | 7175 |
|
|
2023
Q3 | $19K | Sell |
916
-40,224
| -98% | -$1.58M | ﹤0.01% | 6658 |
|
|
2023
Q2 | $2.78M | Buy |
41,140
+40,108
| +3,886% | +$16.6M | ﹤0.01% | 1711 |
|
|
2023
Q1 | $481K | Buy |
1,032
+568
| +122% | +$301K | ﹤0.01% | 3306 |
|
|
2022
Q4 | $185K | Buy |
464
+8
| +2% | +$3.06K | ﹤0.01% | 4317 |
|
|
2022
Q3 | $148K | Buy |
456
+100
| +28% | +$32.2K | ﹤0.01% | 5004 |
|
|
2022
Q2 | $93K | Sell |
356
-712
| -67% | -$182K | ﹤0.01% | 5653 |
|
|
2022
Q1 | $320K | Buy |
1,068
+524
| +96% | +$183K | ﹤0.01% | 4453 |
|
|
2021
Q4 | $191K | Sell |
544
-3,392
| -86% | -$1.06M | ﹤0.01% | 5266 |
|
|
2021
Q3 | $2.61M | Hold |
3,936
| – | – | ﹤0.01% | 1827 |
|
|
2021
Q2 | $2.62M | Buy |
3,936
+3,930
| +65,500% | +$2.26M | ﹤0.01% | 1824 |
|
|
2021
Q1 | $510K | Sell |
6
-32
| -84% | -$34.1K | ﹤0.01% | 3341 |
|
|
2020
Q4 | $3.55M | Buy |
38
+27
| +245% | +$28.4K | ﹤0.01% | 1252 |
|
|
2020
Q3 | $1.12M | Buy |
11
+6
| +120% | +$6.46K | ﹤0.01% | 2113 |
|
|
2020
Q2 | $543K | Buy |
5
+1
| +25% | +$929 | ﹤0.01% | 2792 |
|
|
2020
Q1 | $389K | Sell |
4
-8
| -67% | -$7.95K | ﹤0.01% | 2868 |
|
|
2019
Q4 | $1.24M | Buy |
12
+8
| +200% | +$8.17K | ﹤0.01% | 1904 |
|
|
2019
Q3 | $399K | Sell |
4
-11
| -73% | -$12.1K | ﹤0.01% | 2841 |
|
|
2019
Q2 | $1.7M | Sell |
15
-2
| -12% | -$2.19K | ﹤0.01% | 1432 |
|
|
2019
Q1 | $2.33M | Hold |
17
| – | – | 0.01% | 1236 |
|
|
2018
Q4 | $1.95M | Buy |
17
+11
| +183% | +$12.4K | 0.01% | 1112 |
|
|
2018
Q3 | $935K | Sell |
6
-3
| -33% | -$4.62K | ﹤0.01% | 1964 |
|
|
2018
Q2 | $1.38M | Buy |
9
+8
| +800% | +$10.4K | 0.01% | 1471 |
|
|
2018
Q1 | $1K | Sell |
1
-6
| -86% | -$7.9K | ﹤0.01% | 5608 |
|
|
2017
Q4 | $77K | Buy |
7
+3
| +75% | +$3.76K | ﹤0.01% | 2031 |
|
|
2017
Q3 | $149K | Buy |
4
+2
| +100% | +$2.11K | 0.01% | 1407 |
|
|
2017
Q2 | $36K | Sell |
2
-2
| -50% | -$1.39K | ﹤0.01% | 2692 |
|
|
2017
Q1 | $18K | Buy |
4
+3
| +300% | +$1.83K | ﹤0.01% | 3344 |
|
|
2016
Q4 | $5K | Sell |
1
-1
| -50% | -$499 | ﹤0.01% | 4340 |
|
|
2016
Q3 | $6K | Sell |
2
-5
| -71% | -$2.35K | ﹤0.01% | 4098 |
|
|
2016
Q2 | $22K | Buy |
7
+4
| +133% | +$1.83K | ﹤0.01% | 2808 |
|
|
2016
Q1 | $14K | Sell |
3
-2
| -40% | -$997 | ﹤0.01% | 3135 |
|
|
2015
Q4 | $45K | Sell |
5
-2
| -29% | -$1.33K | ﹤0.01% | 1996 |
|
|
2015
Q3 | $21K | Buy |
+7
| New | +$4.24K | ﹤0.01% | 2732 |
|
Other funds holding KYNB
AC
CCM
Simplex Trading's KYNB Position: Q1 2025 in Review
Simplex Trading sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 1,540 shares — an estimated $18.5K sold.
Simplex Trading first reported a position in KYNB in Q2 2016 and held it in 30 quarters. The position peaked at $2.48M in Q2 2021. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.
- Simplex Trading reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 1,540 Kyntra Bio shares in Q1 2025, an estimated $18.5K.
- Simplex Trading first reported a position in Kyntra Bio in Q2 2016 and held it in 30 quarters.
- Simplex Trading's Kyntra Bio position peaked at $2.48M in Q2 2021.
- 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.